
Genevieve S. Alley
Examiner (ID: 9678, Phone: (571)270-1111 , Office: P/1617 )
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1617 |
| Total Applications | 843 |
| Issued Applications | 465 |
| Pending Applications | 100 |
| Abandoned Applications | 305 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19216109
[patent_doc_number] => 20240180813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => AMINOSILOXANE ESTER COPOLYMER AND METHODS FOR THE PREPARATION AND USE OF THE COPOLYMER
[patent_app_type] => utility
[patent_app_number] => 18/552681
[patent_app_country] => US
[patent_app_date] => 2022-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552681
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552681 | AMINOSILOXANE ESTER COPOLYMER AND METHODS FOR THE PREPARATION AND USE OF THE COPOLYMER | May 30, 2022 | Pending |
Array
(
[id] => 19343471
[patent_doc_number] => 20240252434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => LIPID COMPOUND AND USE THEREOF IN DELIVERY OF NUCLEIC ACID
[patent_app_type] => utility
[patent_app_number] => 18/558335
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6807
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 360
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18558335
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/558335 | LIPID COMPOUND AND USE THEREOF IN DELIVERY OF NUCLEIC ACID | May 22, 2022 | Issued |
Array
(
[id] => 19343471
[patent_doc_number] => 20240252434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => LIPID COMPOUND AND USE THEREOF IN DELIVERY OF NUCLEIC ACID
[patent_app_type] => utility
[patent_app_number] => 18/558335
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6807
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 360
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18558335
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/558335 | LIPID COMPOUND AND USE THEREOF IN DELIVERY OF NUCLEIC ACID | May 22, 2022 | Issued |
Array
(
[id] => 17836369
[patent_doc_number] => 20220273674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => EXTENDED-RELEASE DRUG DELIVERY COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/744932
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744932
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/744932 | EXTENDED-RELEASE DRUG DELIVERY COMPOSITIONS | May 15, 2022 | Pending |
Array
(
[id] => 18056384
[patent_doc_number] => 20220387470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => METHODS OF MODULATING IMMUNE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/743679
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743679
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/743679 | METHODS OF MODULATING IMMUNE ACTIVITY | May 12, 2022 | Pending |
Array
(
[id] => 19246633
[patent_doc_number] => 20240197617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => ANTI-AGING COSMETIC COMPOSITION BASED ON RESVERATROL AND MAGNOLIA
[patent_app_type] => utility
[patent_app_number] => 17/788895
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788895
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/788895 | ANTI-AGING COSMETIC COMPOSITION BASED ON RESVERATROL AND MAGNOLIA | May 9, 2022 | Pending |
Array
(
[id] => 18020979
[patent_doc_number] => 20220372478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => STABILIZATION OF RNA FOR EXOGENOUS RNAi AGRICULTURAL APPLICATIONS AND FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/737426
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25880
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737426
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/737426 | STABILIZATION OF RNA FOR EXOGENOUS RNAi AGRICULTURAL APPLICATIONS AND FORMULATIONS | May 4, 2022 | Pending |
Array
(
[id] => 18273670
[patent_doc_number] => 11612591
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-28
[patent_title] => Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea
[patent_app_type] => utility
[patent_app_number] => 17/735820
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25986
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735820
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/735820 | Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea | May 2, 2022 | Issued |
Array
(
[id] => 17828248
[patent_doc_number] => 20220265552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => ESLICARBAZEPINE SUSPENSION
[patent_app_type] => utility
[patent_app_number] => 17/734420
[patent_app_country] => US
[patent_app_date] => 2022-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17454
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17734420
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/734420 | ESLICARBAZEPINE SUSPENSION | May 1, 2022 | Pending |
Array
(
[id] => 19300119
[patent_doc_number] => 20240228688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => POLYMER AND COMPOSITION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/288970
[patent_app_country] => US
[patent_app_date] => 2022-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16934
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18288970
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/288970 | POLYMER AND COMPOSITION THEREOF | Apr 28, 2022 | Pending |
Array
(
[id] => 19657025
[patent_doc_number] => 20240424090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 18/287669
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287669
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287669 | COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY | Apr 19, 2022 | Pending |
Array
(
[id] => 19657025
[patent_doc_number] => 20240424090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 18/287669
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287669
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287669 | COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY | Apr 19, 2022 | Pending |
Array
(
[id] => 18618549
[patent_doc_number] => 11751570
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Aluminosilicate glass with phosphorus and potassium
[patent_app_type] => utility
[patent_app_number] => 17/722688
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 20293
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17722688
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/722688 | Aluminosilicate glass with phosphorus and potassium | Apr 17, 2022 | Issued |
Array
(
[id] => 19316648
[patent_doc_number] => 20240238188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => OILY COSMETIC
[patent_app_type] => utility
[patent_app_number] => 18/289468
[patent_app_country] => US
[patent_app_date] => 2022-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7870
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 366
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289468
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/289468 | OILY COSMETIC | Apr 13, 2022 | Pending |
Array
(
[id] => 17748012
[patent_doc_number] => 20220226215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => PHOTOPROTECTIVE COMPOSITIONS COMPRISING A DIBENZOYLMETHANE DERIVATIVE, A MEROCYANINE COMPOUND AND A COMPOUND CAPABLE OF ACCEPTING THE TRIPLET EXCITED LEVEL ENERGY OF THE DIBENZOYLMETHANE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/715355
[patent_app_country] => US
[patent_app_date] => 2022-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17715355
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/715355 | PHOTOPROTECTIVE COMPOSITIONS COMPRISING A DIBENZOYLMETHANE DERIVATIVE, A MEROCYANINE COMPOUND AND A COMPOUND CAPABLE OF ACCEPTING THE TRIPLET EXCITED LEVEL ENERGY OF THE DIBENZOYLMETHANE COMPOUND | Apr 6, 2022 | Abandoned |
Array
(
[id] => 17958836
[patent_doc_number] => 20220339416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => SILK FIBROIN-BASED MICRONEEDLES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/714025
[patent_app_country] => US
[patent_app_date] => 2022-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714025
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/714025 | SILK FIBROIN-BASED MICRONEEDLES AND USES THEREOF | Apr 4, 2022 | Pending |
Array
(
[id] => 20315203
[patent_doc_number] => 12453742
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Bowel cleansing chemical composition and associated use therefore
[patent_app_type] => utility
[patent_app_number] => 17/655615
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 0
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17655615
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/655615 | Bowel cleansing chemical composition and associated use therefore | Mar 20, 2022 | Issued |
Array
(
[id] => 18642353
[patent_doc_number] => 11766406
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Soft gelatin capsules containing a mixture of analgesics and decongestants, expectorants, antitussives and/or antihistamines
[patent_app_type] => utility
[patent_app_number] => 17/692521
[patent_app_country] => US
[patent_app_date] => 2022-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5547
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692521
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/692521 | Soft gelatin capsules containing a mixture of analgesics and decongestants, expectorants, antitussives and/or antihistamines | Mar 10, 2022 | Issued |
Array
(
[id] => 19158151
[patent_doc_number] => 20240150858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => USE OF MIXTURES COMPRISING GLYCEROL AND GLYCERIDES OF ORGANIC ACIDS IN AGRICULTURAL AND FORESTRY
[patent_app_type] => utility
[patent_app_number] => 18/280528
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18280528
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/280528 | USE OF MIXTURES COMPRISING GLYCEROL AND GLYCERIDES OF ORGANIC ACIDS IN AGRICULTURAL AND FORESTRY | Mar 7, 2022 | Pending |
Array
(
[id] => 17670800
[patent_doc_number] => 20220183967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => LIMITED PARTICLE SIZE TRIAMCINOLONE AND MOXIFLOXACIN COMPOSITIONS AND ASSOCIATED METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/686371
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17686371
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/686371 | Limited particle size triamcinolone and moxifloxacin compositions and associated methods of use | Mar 2, 2022 | Issued |